和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

未开盘 02-03 16:08:20

12.550

+0.050

+0.40%

最高12.840	最低12.330	成交量506.20万
今开12.590	昨收12.500	日振幅4.08%
总市值84.34亿	流通市值84.34亿	总股本6.72亿
成交额6,342万	换手率0.75%	流通股本6.72亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":12.55,"timestamp":1770106100003,"preClose":12.5,"halted":0,"volume":5062000,"delay":0,"changeRate":0.0040000000000000565,"floatShares":672000000,"shares":672000000,"eps":0.05028111557270752,"marketStatus":"未开盘","change":0.05,"latestTime":"02-03 16:08:20","open":12.59,"high":12.84,"low":12.33,"amount":63419360,"amplitude":0.0408,"askPrice":12.62,"askSize":13000,"bidPrice":12.55,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":0.25083788784900707,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770168600000},"marketStatusCode":0,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":12.5,"openAndCloseTimeList":[[1770082200000,1770091200000],[1770094800000,1770105600000]],"volumeRatio":1.89075,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256","defaultTab":"news","newsList":[{"id":"2608544688","title":"每日卖空追踪 | 和誉-B 02月02日卖空量成交10.2万股，卖空比例为2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608544688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608544688?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021029,"startTime":"0","endTime":"0","summary":"和誉-B北京时间02月02日，股价较前一交易日持平，卖空量成交10.2万股，较上一交易日减少61.51%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163518a4728cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163518a4728cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU2476274308.USD","LU2778985437.USD","IE00B5MMRT66.SGD","02256","LU2488822045.USD","BK1161","IE00BPRC5H50.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2608854433","title":"和誉-B02月02日主力净流出95.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608854433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608854433?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020142,"startTime":"0","endTime":"0","summary":"02月02日，和誉-B股价收平报12.50元，成交金额4276.8万元，换手率0.52%，振幅4.24%，量比1.47。和誉-B今日主力资金净流出95.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.01%，主力资金累计净流出541.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出290.8万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162005a4727c4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162005a4727c4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274720.SGD","LU2778985437.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274308.USD","02256","IE00B543WZ88.USD","BK1161","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2607089892","title":"每日卖空追踪 | 和誉-B 01月29日卖空量成交11.1万股，卖空比例为2.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607089892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607089892?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675430,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月29日，涨1.78%，卖空量成交11.1万股，较上一交易日减少37.29%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164015a463eae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164015a463eae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","LU2488822045.USD","BK1161","IE00B543WZ88.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","02256","LU2476274308.USD"],"gpt_icon":0},{"id":"2606765783","title":"和誉-B盘中异动 股价大跌5.02%报12.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606765783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606765783?lang=zh_cn&edition=full","pubTime":"2026-01-28 11:26","pubTimestamp":1769570760,"startTime":"0","endTime":"0","summary":"2026年01月28日早盘11时26分，和誉-B股票出现波动，股价急速下挫5.02%。截至发稿，该股报12.300港元/股，成交量37.6万股，换手率0.06%，振幅5.10%。资金方面，该股资金流入136.281万港元，流出311.534万港元。和誉-B股票所在的生物技术行业中，整体涨幅为0.59%。该公司拥有两款核心候选产品ABSK011和 ABSK091,以及12款其他在研产品。ABSK091 是一种分子靶向候选产品,也是 FGFR亚型 1、2和3的强效和选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128112601953ea8d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128112601953ea8d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2778985437.USD","IE00B5MMRT66.SGD","02256","IE00BPRC5H50.USD","LU2488822045.USD","IE00B543WZ88.USD","LU2476274308.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2606976573","title":"每日卖空追踪 | 和誉-B 01月27日卖空量成交7万股，卖空比例为9.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606976573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606976573?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502631,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月27日，跌3.93%，卖空量成交7万股，较上一交易日减少70.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164045a6b2375b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164045a6b2375b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2476274720.SGD","LU2476274308.USD","LU2488822045.USD","IE00BPRC5H50.USD","02256","LU2778985437.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2606757765","title":"和誉-B01月27日主力净流出54.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606757765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606757765?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:16","pubTimestamp":1769501766,"startTime":"0","endTime":"0","summary":"01月27日, 和誉-B股价跌3.93%，报收12.95元，成交金额980.2万元，换手率0.11%，振幅4.82%，量比0.59。和誉-B今日主力资金净流出54.2万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.27%，主力资金累计净流入114.6万元；近20日主力资金累计净流入478.1万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162640a6b2276b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162640a6b2276b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1161","02256","LU2488822045.USD","LU2778985437.USD","LU2476274308.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2606223053","title":"每日卖空追踪 | 和誉-B 01月26日卖空量成交12.3万股，卖空比例为6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606223053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606223053?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416229,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月26日，跌2.81%，卖空量成交12.3万股，较上一交易日减少26.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163921a6ad75fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163921a6ad75fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2778985437.USD","IE00BPRC5H50.USD","02256","LU2488822045.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2476274308.USD","LU2476274720.SGD"],"gpt_icon":0},{"id":"2605238689","title":"每日卖空追踪 | 和誉-B 01月23日卖空量成交5.3万股，卖空比例为4.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605238689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605238689?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157029,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月23日，跌2.6%，卖空量成交5.3万股，较上一交易日减少70.72%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164008a6a44d46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164008a6a44d46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU2476274720.SGD","LU2476274308.USD","LU2778985437.USD","IE00B5MMRT66.SGD","02256","BK1161","IE00BPRC5H50.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2605108801","title":"每日卖空追踪 | 和誉-B 01月21日卖空量成交18.6万股，卖空比例为10.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605108801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605108801?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984231,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月21日，涨2.88%，卖空量成交18.6万股，较上一交易日减少6.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165426a444d464&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165426a444d464&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","02256","LU2488822045.USD","LU2778985437.USD","BK1161","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2605108822","title":"和誉-B01月21日主力净流入111.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2605108822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605108822?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:15","pubTimestamp":1768983345,"startTime":"0","endTime":"0","summary":"01月21日, 和誉-B股价涨2.88%，报收14.28元，成交金额2538.0万元，换手率0.27%，振幅4.61%，量比1.74。和誉-B今日主力资金净流入111.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.74%，主力资金累计净流入36.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入507.2万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121162904a444bbf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121162904a444bbf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","LU2476274308.USD","LU2476274720.SGD","02256","LU2488822045.USD","LU2778985437.USD","BK1161","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2604917691","title":"每日卖空追踪 | 和誉-B 01月20日卖空量成交5.9万股，卖空比例为7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604917691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604917691?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:30","pubTimestamp":1768897829,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月20日，跌1.35%，卖空量成交5.9万股，较上一交易日减少71.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165242a4404968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165242a4404968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2476274720.SGD","LU2476274308.USD","LU2488822045.USD","IE00BPRC5H50.USD","02256","LU2778985437.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2603958686","title":"中泰证券：维持和誉-B(02256)“买入”评级 推进ABSK021中美上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2603958686","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603958686?lang=zh_cn&edition=full","pubTime":"2026-01-16 09:36","pubTimestamp":1768527370,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中泰证券发布研报称，维持和誉-B“买入”评级，医药核心产品ABSK021近日获得NMPA批准上市，成为中国首个自主研发的腱鞘巨细胞瘤治疗药物，其NDA也已获FDA受理。中泰证券主要观点如下：近期事件近日，根据NMPA官网最新公示，公司核心产品ABSK021的NDA已获得批准，用于治疗手术切除可能会导致功能受限或出现较严重并发症的症状性成人腱鞘巨细胞瘤患者。随后，ABSK021用于腱鞘巨细胞瘤患者系统性治疗的NDA亦获FDA正式受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600918","02256"],"gpt_icon":0},{"id":"2603648611","title":"每日卖空追踪 | 和誉-B 01月14日卖空量成交6.1万股，卖空比例为3.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603648611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603648611?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:30","pubTimestamp":1768379428,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月14日，跌0.27%，卖空量成交6.1万股，较上一交易日减少45.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164209a4c272ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164209a4c272ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","LU2778985437.USD","BK1161","IE00BPRC5H50.USD","02256","IE00B543WZ88.USD","LU2476274308.USD","LU2476274720.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2603648646","title":"从研发到产业落地 贝捷迈 ® 申报受理助力和誉医药进阶","url":"https://stock-news.laohu8.com/highlight/detail?id=2603648646","media":"中国工业新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603648646?lang=zh_cn&edition=full","pubTime":"2026-01-14 09:49","pubTimestamp":1768355340,"startTime":"0","endTime":"0","summary":"贝捷迈由和誉医药自主研发，并授权默克公司负责其在全球的商业化。此次贝捷迈NDA获FDA受理，主要基于全球多中心、随机、双盲、安慰剂对照III期MANEUVER研究的积极结果。随着贝捷迈在全球主要市场的陆续申报及未来获批，该药品有望为全球TGCT患者提供一种每日一次、口服、有效且耐受性良好的创新治疗选择，有助于满足该疾病领域未竟的临床需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114120347a4c16cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114120347a4c16cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","IE00B543WZ88.USD","LU2488822045.USD","LU2476274720.SGD","LU2778985437.USD","BK1515","IE00B5MMRT66.SGD","BK1161","IE00BPRC5H50.USD","LU2476274308.USD","02256","BK1574"],"gpt_icon":0},{"id":"2603157456","title":"和誉-B(02256)贝捷迈® NDA获FDA受理 用于治TGCT","url":"https://stock-news.laohu8.com/highlight/detail?id=2603157456","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603157456?lang=zh_cn&edition=full","pubTime":"2026-01-13 12:17","pubTimestamp":1768277830,"startTime":"0","endTime":"0","summary":"2025年12 月，贝捷迈获中国国家药品监督管理局批准上市。用于手术切除可能会导致功能受限或出现较严重并发症的症状性TGCT成年患者。此次贝捷迈的NDA获FDA受理，基于全球多中心、随机、双盲、安慰剂对照III 期MANEUVER研究的积极有效性及安全性结果。若不及时治疗或出现复发，TGCT可能对骨骼、关节及周围组织造成不可逆的损伤。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B(02256)贝捷迈® NDA获FDA受理 用于治TGCT","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU2488822045.USD","IE00B543WZ88.USD","LU2476274720.SGD","02256","LU2778985437.USD","LU2476274308.USD"],"gpt_icon":0},{"id":"1161090284","title":"和誉-B子公司创新药物Pimicotinib获美国FDA正式受理新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1161090284","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161090284?lang=zh_cn&edition=full","pubTime":"2026-01-13 12:08","pubTimestamp":1768277295,"startTime":"0","endTime":"0","summary":"和誉-B旗下研发的集落刺激因子1受体抑制剂Pimicotinib迎来重要里程碑——美国食品药品监督管理局（FDA）已正式受理其新药申请。该突破性进展标志着这款针对自身免疫性疾病治疗的创新药物正式进入FDA审评流程，为全球患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","02256","IE00B5MMRT66.SGD","LU2476274720.SGD","BK1161","LU2476274308.USD","IE00B543WZ88.USD","LU2488822045.USD","LU2778985437.USD"],"gpt_icon":0},{"id":"2603578470","title":"重磅进展！和誉医药(02256)腱鞘巨细胞瘤新药贝捷迈®上市申请获FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2603578470","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603578470?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:21","pubTimestamp":1768267282,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年1月13日，和誉医药今日宣布，其自主研发的新型、口服、高选择性且高效的小分子集落刺激因子1受体抑制剂贝捷迈用于腱鞘巨细胞瘤患者系统性治疗的新药申请已获美国食品药品监督管理局正式受理。此次贝捷迈NDA获FDA受理，主要基于全球多中心、随机、双盲、安慰剂对照III期MANEUVER研究的积极结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2476274308.USD","BK1161","BK1574","159938","IE00BPRC5H50.USD","LU2476274720.SGD","BK1515","09939","IE00B5MMRT66.SGD","LU2488822045.USD","02256","LU2778985437.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1155178164","title":"和誉-B宣布FDA受理Pimicotinib治疗腱鞘巨细胞瘤的新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1155178164","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155178164?lang=zh_cn&edition=full","pubTime":"2026-01-13 08:55","pubTimestamp":1768265716,"startTime":"0","endTime":"0","summary":"和誉-B（Abbisko Therapeutics）今日宣布，其创新药物Pimicotinib针对腱鞘巨细胞瘤（TGCT）的新药申请（NDA）已获得美国食品药品监督管理局（FDA）正式受理。这一关键进展标志着Pimicotinib在全球化开发与商业化进程中迈出重要一步，为TGCT患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256","IE00BPRC5H50.USD","LU2476274720.SGD","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1161"],"gpt_icon":0},{"id":"2603547737","title":"每日卖空追踪 | 和誉-B 01月12日卖空量成交3万股，卖空比例为3.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603547737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603547737?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206627,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月12日，涨0.56%，卖空量成交3万股，较上一交易日减少56.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164837a4b9d3cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164837a4b9d3cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","IE00BPRC5H50.USD","BK1161","02256","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274720.SGD","LU2476274308.USD"],"gpt_icon":0},{"id":"2603547784","title":"和誉-B01月12日获主力加仓46.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603547784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603547784?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205731,"startTime":"0","endTime":"0","summary":"01月12日, 和誉-B股价涨0.56%，报收14.48元，成交金额1192.5万元，换手率0.12%，振幅3.33%，量比0.65。和誉-B今日主力资金净流入46.6万元，上一交易日主力净流入40.6万元。该股近5个交易日上涨4.88%，主力资金累计净流入182.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入499.4万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112162216a710ae15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112162216a710ae15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2778985437.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU2476274720.SGD","BK1161","LU2476274308.USD","IE00BPRC5H50.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":-0.0309},{"period":"1month","weight":-0.0361},{"period":"3month","weight":-0.1392},{"period":"6month","weight":0.045},{"period":"1year","weight":1.6037},{"period":"ytd","weight":-0.0354}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":0.0188},{"period":"3month","weight":0.0347},{"period":"6month","weight":0.0699},{"period":"1year","weight":0.3273},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家临床阶段生物制药公司。该公司致力于发现和开发创新差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011和 ABSK091，以及12款其他在研产品。ABSK011是一种强效且高选择性的成纤维细胞生长因子受体4(FGFR4) 小分子抑制剂。ABSK091 是一种分子靶向候选产品，也是 FGFR亚型 1、2和3的强效和选择性抑制剂。该公司的产品主要用于肝细胞癌(HCC)、尿路上皮癌(UC) 和胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.122249},{"month":2,"riseRate":0.8,"avgChangeRate":0.038061},{"month":3,"riseRate":0.5,"avgChangeRate":0.054417},{"month":4,"riseRate":0.25,"avgChangeRate":-0.010041},{"month":5,"riseRate":0.25,"avgChangeRate":0.029375},{"month":6,"riseRate":0.5,"avgChangeRate":0.006841},{"month":7,"riseRate":0.75,"avgChangeRate":0.047273},{"month":8,"riseRate":0.5,"avgChangeRate":0.114048},{"month":9,"riseRate":0.75,"avgChangeRate":0.043844},{"month":10,"riseRate":0.5,"avgChangeRate":-0.043137},{"month":11,"riseRate":0.6,"avgChangeRate":0.159978},{"month":12,"riseRate":0,"avgChangeRate":-0.092694}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}